Dublin, Ireland, 05 January 2021 – Ovoca Bio plc (LSE: OVB; ISE: OVXA), a biopharmaceutical company with a focus on women's health, today announces that a new Marketing Authorisation ("MA") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results